Description
The Tesamorelin peptide integrates a trans-3-hexenoic acid group attached to the tyrosine residue at the N-terminus. In research settings, it is studied for its ability to bind GHRH receptors in the anterior pituitary, promoting pulsatile release of growth hormone to drive visceral fat lipolysis and improve overall metabolic parameters.
| Technical Specification | Details |
| Product Name | Tesamorelin |
| Available Sizes & Prices | 10 mg ($89 NZD) |
| Sequence | trans-hexenoyl-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH₂ |
| Molecular Formula | C₂₂₁H₃₆₆N₇₂O₆₇S |
| Molecular Weight | 5135.9 g/mol |
| Purity Grade | ≥99% purity (HPLC & Mass Spectrometry verified) |
| Form & Appearance | White lyophilized powder |
| Primary Category | Metabolic |
| Primary Research Focus | Visceral adipose reduction, endogenous GHRH stimulation, IGF-1 regulation |
| Storage Instructions | Lyophilized: -20°C (Long-term) | Reconstituted: 2°C–8°C |

Reviews
There are no reviews yet.